neurotransmitter
Enable an agent to identify a substance acting as a neurotransmitter, evaluate evidence for that role in a defined biological context, and determine appropriate interpretation, measurement and handling.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
recalled by Codex without web access - no source was read
Researched by: Codex
Purpose and description
Enable an agent to identify a substance acting as a neurotransmitter, evaluate evidence for that role in a defined biological context, and determine appropriate interpretation, measurement and handling.
A neurotransmitter is an endogenous chemical messenger released by a neuron that acts on receptors of another cell to transmit or modulate a signal.
It can be Assess whether a candidate substance has sufficient evidence for a neurotransmitter role in a particular system.; Trace a signaling episode from transmitter availability through release, target action and termination.; Compare receptor-dependent responses without assuming a universal effect for the substance.; Select measurements that distinguish tissue abundance, extracellular release and functional response.; Assess whether a proposed experimental perturbation isolates synthesis, release, target engagement or clearance.; Check whether a material preparation is suitable for the intended assay and handling conditions..
Distinguishing features
A neurotransmitter is identified by evidence of a signaling role involving neuronal release and target action; chemical identity alone does not establish that role.
A substance detected in neural tissue is not thereby a neurotransmitter: its participation in communication must be distinguished from metabolic presence or experimental contamination.
A receptor agonist can mimic a transmitter without being an endogenous neurotransmitter in the system examined.
Hormone, neurotransmitter and neuromodulator labels can overlap for the same substance; classify the particular source, delivery route and action rather than requiring mutually exclusive substance classes.
Vesicular storage and a postsynaptic membrane receptor are not universal requirements; evaluate alternative release routes and intracellular targets where relevant.
Scope
+ Chemical identity, molecular form and material preparation when applicable
+ Evidence that a substance serves as a neurotransmitter in a specified organism, circuit and target
+ Synthesis, availability, storage and release mechanisms
+ Receptor or molecular target engagement and context-dependent effects
+ Transport, degradation, diffusion and other signal-termination mechanisms
+ Measurement validity and constraints on experimental use
- Complete models of neurons, synapses, neural circuits or nervous systems
- Hormonal or metabolic functions unrelated to the specified neurotransmission context
- Drug products and therapeutic prescribing decisions
- Diseases attributed to altered neurotransmission
- Industrial production processes and laboratory equipment design
Characteristics
- Chemical identity and form
- Chemical name; structure or peptide sequence; stereochemistry; protonation or salt form; applicable CAS, PubChem or other identifiers Separates the biologically active entity from salts, precursors, metabolites and experimental preparations.
- Neurotransmitter role evidence
- Proposed; supported in a specified context; disputed; insufficiently assessed, with supporting evidence Prevents a context-specific or tentative assignment from becoming a universal classification.
- Biological signaling context
- Organism, tissue, circuit, source cell, target cell or compartment, developmental stage and experimental condition Defines where claims about release and action apply.
- Release mechanism
- Vesicular exocytosis; nonvesicular release; production followed by diffusion; other documented mechanism; unresolved Determines which evidence and interventions can establish signal delivery.
- Target and response coupling
- Receptor subtype or other molecular target linked to a measured cellular response Avoids assigning a fixed excitatory or inhibitory effect to the molecule independently of its target.
- Local transmitter concentration
- mol/L with compartment, sampling volume, time resolution and measurement method Distinguishes local signaling exposure from bulk tissue abundance.
- Signal time course
- Onset, peak latency and decay in ms or s, with the measured chemical or biological endpoint Separates transmitter clearance from receptor activation and downstream response duration.
- Signal termination route
- Transporter, enzyme, uptake cell, diffusion pathway or chemical reaction with supporting context Explains how exposure ends and where perturbations may change signaling.
- Preparation quality and stability
- Purity, concentration, solvent, pH, storage conditions, degradation assessment and expiry when applicable Connects experimental usability and handling decisions to the actual material.
Also called
Where this came from
wikidata · CC0 1.0
Also registered as vr.tr.neurotransmitter
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 17 findings · 27 questions.
Identity and neurotransmitter role Connect the chemical entity to evidence for its role in neuronal communication.
Neurotransmitter is a functional classification spanning different chemical entities, not a single composition or universal behavior.
Molecular identity
Resolve the active molecule and distinguish related chemical forms.
Active entity and preparation
Record which molecular entity is implicated and how it relates to the material measured or supplied.
- What structure, stereochemistry or peptide sequence identifies the proposed transmitter? definition
- Does the recorded identifier refer to the active entity, a salt, a precursor, a metabolite or a mixture? boundary
Contextual role evidence
Assess neurotransmitter status within an explicitly bounded biological system.
Evidence for neuronal communication
Separate observed presence from evidence of release and causally relevant target action.
- Which observations establish neuronal release and a target response attributable to this substance in the specified system? provenance
- In this context, how is its neurotransmitter role distinguished from or combined with endocrine, metabolic or neuromodulatory roles? boundary
Availability and release Describe how a neuron obtains the transmitter and makes it available to targets.
A signaling model must distinguish production and storage capacity from actual release.
Synthesis and available pools
Locate production, processing and storage relevant to signaling.
Signaling pool maintenance
Record how precursors, processing, transport and compartmentation support transmitter availability.
- Which cells, precursors and processing steps supply the transmitter used in this signaling context? provenance
- Is the relevant supply stored in vesicles, present in another pool or synthesized on demand, and how is that established? measurement
Release and delivery
Characterize the trigger, mechanism and spatial route of transmitter delivery.
Release event
Distinguish physiological signal delivery from leakage, injury and externally applied substance.
- What triggers release or production, and what evidence identifies the mechanism rather than cell damage or leakage? provenance
- Does delivery occur across a synaptic cleft, through extrasynaptic space or by another route, and over what measured distance? measurement
Target action Connect transmitter exposure to molecular engagement and cellular or circuit effects.
The effect of a transmitter depends on target expression, coupling and physiological conditions.
Molecular recognition
Identify receptors or other molecular targets mediating the response.
Target engagement evidence
Associate the transmitter with specific targets while distinguishing binding from functional activation.
- Which receptor subtypes or other molecular targets mediate the response, and where are they located? definition
- Which binding or functional measurements support engagement, and under what concentration and assay conditions? measurement
Context-dependent response
Describe the response at the level actually measured.
Response sign and scale
Separate molecular, cellular and circuit outcomes and preserve conditions affecting their interpretation.
- What changes in conductance, membrane potential, intracellular signaling or release probability follow exposure? measurement
- Which target properties and physiological conditions determine whether the observed effect increases, decreases or otherwise modifies activity? boundary
Termination and adaptation Track removal of the transmitter and changes in responsiveness during repeated exposure.
Signal duration depends on both extracellular availability and the response machinery.
Clearance and chemical fate
Identify mechanisms ending local transmitter exposure.
Termination pathways
Record uptake, degradation, diffusion or reaction pathways and the fate of resulting material.
- Which transporters, enzymes, cells or physical processes reduce transmitter availability at the target? definition
- What measurements establish clearance kinetics, and do resulting metabolites or recycled pools contribute to subsequent signaling? measurement
Feedback and responsiveness
Represent regulation of release and target sensitivity over time.
Repeated exposure effects
Distinguish changes in transmitter supply from feedback, desensitization and downstream adaptation.
- What evidence shows feedback on transmitter synthesis or release, including any autoreceptor involvement? provenance
- How does the response change with repeated exposure, and which measurements distinguish depletion, target desensitization and clearance changes? measurement
Measurement and experimental use Establish what measurements support and which preparations and interventions are fit for purpose.
Bulk abundance, local release and biological activity are different observables, while experimental materials can differ from the endogenous entity.
Assay interpretation
Match analytical claims to specificity, sampling and temporal resolution.
Observable and assay limits
Record whether an assay measures the chemical itself, a proxy or a downstream response.
- Does the method measure total tissue content, extracellular concentration, release events, target occupancy or a functional response? measurement
- What calibration, selectivity controls and spatial and temporal limits constrain attribution to this transmitter? measurement
Preparations and perturbations
Connect experimental actions to material identity and interpretable effects.
Fit-for-purpose intervention
Assess preparation quality and intervention specificity before interpreting experimental outcomes.
- What purity, solvent, pH, stability and substance-specific handling information apply to the exact preparation being used? action
- Which controls are needed to attribute an intervention's effect to transmitter synthesis, release, target action or clearance rather than other mechanisms? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- This describes a biological role shared by many substances, not one material with a common formula, purity specification, melting point, or hazard classification.
- No universal concentration or kinetic range applies; measurements require a named transmitter, compartment, organism, and method.
- Definitions differ in their treatment of gaseous and other nonclassical messengers; vesicular storage and release are not universal across the broader category.
- Which of these check these first hold for the sense of neurotransmitter this model covers, and on what evidence? provenance
Kinds and varieties
Recalled without web access and unsourced; every item is a lead to verify.
- Amino acid transmitters, such as glutamate and glycine
- Monoamines, such as dopamine and serotonin
- Acetylcholine
- Purines, such as ATP
- Neuropeptides, such as substance P
- Gaseous transmitters, such as nitric oxide
- Which of these kinds and varieties hold for the sense of neurotransmitter this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- CAS Registry Number - Two to seven digits, a hyphen, two digits, a hyphen, and one check digit - Identifies individual chemical substances; neurotransmitter is a functional category with no single CAS number. Salts and other chemical forms may have separate records.
- PubChem Compound ID (CID) - Positive integer - Identifies individual chemical structures rather than neurotransmitter function as a category.
- Which of these identifiers and schemes hold for the sense of neurotransmitter this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Mediates communication between neurons and from neurons to muscle or gland cells.
- Supports experimental investigation of receptors, synapses, and neural circuits.
- Provides targets for medicines that alter transmitter synthesis, release, receptor activation, reuptake, or degradation.
- Selected neurotransmitters, including dopamine and norepinephrine, are also administered as medicines.
- Which of these real-world use hold for the sense of neurotransmitter this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Excessive glutamate receptor activation can cause excitotoxic neuronal injury.
- Disrupted synthesis, release, clearance, or receptor function can impair neural signaling.
- Effects depend on receptor subtype and target cell; a transmitter cannot always be classified as intrinsically excitatory or inhibitory.
- Chemical handling hazards depend on the particular molecule, formulation, concentration, and route of exposure.
- Which of these failure modes and hazards hold for the sense of neurotransmitter this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- Norepinephrine and noradrenaline name the same molecule; epinephrine and adrenaline likewise name the same molecule, with usage varying between naming systems and regions.
- Which of these regional variation hold for the sense of neurotransmitter this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- Hormone - Hormonal signaling typically reaches targets through circulation; neurotransmission originates from neuronal release onto or near target cells. A molecule can serve both roles.
- Neuromodulator - Emphasizes changes to neuronal excitability or synaptic effectiveness; it overlaps with neurotransmitter rather than defining a mutually exclusive chemical class.
- Neuropeptide - Defined by peptide composition and neuronal production or use; only a subset of neurotransmitters are peptides.
- Neurotransmitter receptor - The receptor is the molecular target that recognizes a transmitter and initiates a cellular response, rather than the released messenger.
- Neurotransmitter precursor - A precursor is used to synthesize a transmitter but does not qualify as a transmitter solely because of that role.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of neurotransmitter this model covers, and on what evidence? provenance
What the second pass must settle
- What operational evidence threshold should this catalogue adopt for neurotransmitter status, particularly for unconventional candidates?
- Which existing Vercy models already own chemical identity, receptor function or neuronal signaling, and should be referenced to avoid duplicate ownership?
- How should the catalogue express overlapping neurotransmitter and neuromodulator roles without imposing an unsupported categorical boundary?
- Which organism, circuit and developmental differences require separate contextual findings for each represented substance?
- Which authoritative sources and assay standards should establish substance-specific identifiers, material properties, handling requirements and confidence in release measurements?